Research progress of CD73 in diseases

doi:10.3877/cma.j.issn.2095-1221.2019.01.012

Abstract

Abstract:

CD73, also known as 5'-nucleotidase, is a ubiquitous glycoprotein linked to the cell membrane via GPI. CD73 has hydrolase activity, which can degrade adenosine 5'-phosphate into adenosine, and then exert the effects of angiogenesis, paracrine and immunosuppression through the interaction of adenosine and various adenosine receptor subtypes. In addition, CD73 can play a non-enzymatic role in mediating cell-to-cell binding and signal transduction. CD73 is associated with many diseases, such as tumors, myocardial injury, brain injury, diabetes mellitus, Toxoplasma invasion, systemic lupus erythematosus, organ transplantation and so on. Adenosine and adenosine receptors produced by CD73 and its hydrolysis affect the physiological and pathological processes of the body. This article reviews the basic and clinical research of CD73 in recent years, and the relationship between basic research and clinical application of CD73.

Key words: CD73, Tumor, Myocardial injury, Brain injury, Toxoplasma infection, Organ transplantation

Yan Wang, Yujie Zhao, Qiong Li, Zhikun Guo. Research progress of CD73 in diseases[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2019, 09(01): 58-64.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxbygxbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-1221.2019.01.012

https://zhxbygxbzz.cma-cmc.com.cn/EN/Y2019/V09/I01/58

Figures/Tables 3

References 38

[1]	Gile J,Eckle T. ADORA2b Signaling in Cardioprotection[J]. J Nat Sci, 2016, 2(10). pii: e222.
[2]	Gao ZW,Wang HP,Fang L, et al. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity[J]. BMC Cancer, 2017, 17(1):135.
[3]	Allard B,Turcotte M,Stagg J. CD73-Generated adenosine: orchestrating the Tumor-Stroma interplay to promote cancer growth[J]. J Biomed Biotechnol, 2012, 16(10):485156.
[4]	Sciarra A,Monteiro I,Ménétrier-Caux C, et al. Correction to:CD73 expression in normal and pathological human hepatobiliopancreatic tissues[J]. Cancer Immunol Immunother, 2019, 68(3):529.
[5]	Sek K,Mølck C,Stewart GD, et al. Targeting adenosine receptor signaling in cancer immunotherapy[J]. Int J Mol Sci, 2018, 19(12). pii: E3837.
[6]	Beavis PA,Stagg J,Darcy PK, et al. CD73:a potent suppressor of antitumor immune responses[J]. Trends Immunol, 2012, 33(5):231-237.
[7]	Whiteside TL,Mandapathil M,Schuler P. The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg)[J]. Curr Med Chem, 2011, 18(34):5217-5223.
[8]	Young A,Ngiow SF,Barkauskas DS, et al. Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responses[J]. Cancer Cell, 2016, 30(3):391-403.
[9]	Wang L,Tang S,Wang Y, et al. Ecto-5-nucleotidase (CD73) promotes tumor growth angiogenesis[J]. Clin Exp Metastasis, 2013, 30(5):671-680.
[10]	Allard B,Turcotte M,Stagg J. Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer[J]. Expert Opin Ther Targets, 2014, 18(8):863-881.
[11]	Giordano G,Febbraro A,Tomaselli E, et al. Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer[J]. J Exp Clin Cancer Res, 2015, 34(1):108.
[12]	Zhi X,Wang Y,Yu J, et al. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer[J]. IUBMB Life, 2012, 64(11):911-920.
[13]	Xie MH,Qin HB,Luo QX, et al. MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73[J]. BMC Cancer, 2017, 17(1):305.
[14]	Yegutkin GG,Marttila-Ichihara F,Karikoski M, et al. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression[J]. Eur J Immunol, 2011, 41(5):1231-1241.
[15]	Sadej R,Skladanowski AC. Dual, enzymatic and non-enzymatic, function of ecto-5'-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells[J]. Acta Biochim Pol, 2012, 59(4):647-652.
[16]	Wang H,Lee S,Lo Nigro C, et al. NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity[J]. Br J Cancer, 2012, 106(8):1446-1452.
[17]	Bonner BF,Rg N,Jacoby C, et al. Ecto-5'-Nucleotidase on immune cells protects from adverse cardiac remodeling[J]. Circ Res, 2013, 113(3):301-312.
[18]	Quast C,Alter C,Ding ZP, et al. Adenosine formed by CD73 on T cells inhibits cardiac inflammation and fibrosis and preserves contractile function in transverse aortic Constriction-Induced heart failure[J]. Circ Heart Fail, 2017, 10(4):e003346.
[19]	Del Ry S,Giannessi D,Maltinti MA, et al. Increased plasma levels of osteopontin are associated with activation of the renin-aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy[J]. Cytokine, 2010, 49(3):325-330.
[20]	Hensel F,Hermann R,Brändlein S, et al. Regulation of the new coexpressed CD55(decay-accelerating factor)receptor on stomach carcinoma cells involved in antibody SC-1-induced apoptosis[J]. Lab Invest, 2001, 81(11):1553-1563.
[21]	Hermes M,Osswald H,Kloor D. Adenosine metabolism and its effect on methylation potential in cultured cells: Methodological considerations[J]. Cell Mol Biol, 2006, 52(S):874-881.
[22]	Lappas CM,Rieger JM,Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4⁺ T cells[J]. J Immunol, 2005, 174(2):1073-1080.
[23]	汪咏梅,向伟,圣蒂·莫尔. CD73对弓形虫侵入宿主细胞及其在细胞内繁殖过程的影响(英文)[J]. 临床儿科杂志, 2010, 28(8):701-709.
[24]	Bours MJ,Swennen EL,Di Virgilio F, et al. PCAdenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation[J]. Pharmacol Ther, 2006, 112(2):358-404.
[25]	Mills JH,Thompson LF,Mueller C, et al. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis[J]. 2008, 105(27):9325-9330.
[26]	Alam MS,Kurtz CC,Rowlett RM, et al. CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and helicobacter felis-Induced gastritis in mice[J]. J Infect Dis, 2009, 199(4):494-504.
[27]	Karhausen J,Haase VH,Colgan SP. Inflammatory hypoxia: role of hypoxia-inducible factor[J]. Cell Cycle, 2005, 4(2):256-258.
[28]	Frantz S,Vincent KA,Feron O, et al. Innate immunity and angiogenesis [J]. Circ Res, 2005, 96(1):15-26.
[29]	Tsutsui S,Schnermann J,Noorbakhsh F, et al. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis[J]. J Neurosci, 2004, 24(6):1521-1529.
[30]	Lee JY,Jhun BS,Oh YT, et al. Activation of adenosine A(3) receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappa B activation in murine BV2 microglial cells[J]. Neurosci Lett, 2006, 396(1):1-6.
[31]	Mahamed DA,Mills JH,Egan CE, et al. CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system[J]. Proc Natl Acad Sci U S A, 2012, 109(40):16312-16317.
[32]	Crikis S,Lu B,Murray-Segal LM, et al. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury[J]. Am J Transplant, 2010, 10(12):2586-2595.
[33]	Ohtsuka T,Changelian PS,Bouis D, et al. Ecto-5'-Nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation[J]. J Immunol, 2010, 185(2):1321-1329.
[34]	Tak E,Jung DH,Kim SH, et al. Protective role of hypoxia-inducible factor-1 alpha-dependent CD39 and CD73 in fulminant acute liver failure[J]. Toxicol Appl Pharmacol, 2017, 314(5):72-81.
[35]	Guzman-Flores JM,Cortez-Espinosa N,Cortés-Garcia JD, et al. Expression of CD73 and a2a receptors in cells from subjects with obesity and type 2 diabetes mellitus[J]. Immunobiology, 2015, 220(8): 976-984.
[36]	Eberle D,Schubert S,Postel K, et al. Increased integration of transplanted CD73-Positive photoreceptor precursors into adult mouse retina[J]. Invest Ophthalmol Vis Sci, 2011, 52(9):6462-6471.
[37]	Wang LY,Li JH,Zhou X, et al. Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma[J]. Onco Targets Ther, 2017, 10(22):5585-5589.
[38]	Della Latta V,Cabiati M,Rocchiccioli S, et al. The role of the adenosinergic system in lung fibrosis[J]. Pharmacol Res, 2013, 76(10):182-189.

Please choose a citation manager

Content to export